Literature DB >> 7426950

The role of surgery in the combined management of metastases from malignant teratomas of testis.

W F Hendry, A Barrett, T J McElwain, D M Wallace, M J Peckham.   

Abstract

Thirty-three patients with malignant testicular teratomas and para-aortic metastases exceeding 2 cm in diameter have been treated with radiotherapy, chemotherapy (vinblastine and bleomycin, with or without cis-platinum) or both, followed by surgical excision of the residual para-aortic mass. Removal of a poorly functioning ipsilateral kidney was necessary in 7 cases (21%) and a segment of vena cava was resected in 2 (12.5%) of 16 patients with primary right-sided tumours. Removal was incomplete in only one patient, who had femoral nerve root involvement, and he subsequently died of secondary haemorrhage (operative mortality 3%). Undifferentiated tumour was found in 8 (61%) of 13 patients (Group 1) after radiotherapy, compared with only 2 (15%) of 13 (Group 2) after chemotherapy and radiotherapy, and 4 (57%) of 7 (Group 3) who had chemotherapy only prior to surgery; however, 3 of the Group 3 patients were referred because of evidence of activity in the para-aortic region.

Entities:  

Mesh:

Year:  1980        PMID: 7426950     DOI: 10.1111/j.1464-410x.1980.tb02917.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  7 in total

Review 1.  [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].

Authors:  A Heidenreich; S Krege; M Flasshove
Journal:  Urologe A       Date:  2004-12       Impact factor: 0.639

Review 2.  Computed tomography in testicular disease: a review.

Authors:  J E Husband; J S Macdonald; M J Peckham
Journal:  J R Soc Med       Date:  1981-06       Impact factor: 5.344

3.  Prognosis of testicular tumour since the introduction of complex therapy.

Authors:  D Frang; L Farkas; F Götz; J Székely
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

4.  A contribution to the treatment of non-seminomatous testicular tumours.

Authors:  J Base; P Navrátil
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

5.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

6.  Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia.

Authors:  H S Klys; D Whillis; G Howard; D J Harrison
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

7.  Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.

Authors:  D Tait; M J Peckham; W F Hendry; P Goldstraw
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.